Cite
MLA Citation
Francesca Palandri et al.. “Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.” Cancer, vol. 126, no. 6, 2020, pp. 1243–1252. http://access.bl.uk/ark:/81055/vdc_100101899705.0x00005c